An investigation examines whether parental prescription opioid use impacts a child’s opioid use and misuse.
The opioid crisis has raised many questions about what leads to the misuse of opioids. Little research has been done into how parental and adolescent prescription use and misuse could be associated. An investigation looks at whether such a link exists.1
Investigators did a cross-sectional, nationally representative study that included parent-adult pairs from the annual 2015-2016 National Survey on Drug Use and Health. The data were collected from January 2015 to December 2017. The exposure was parental past 12-month exclusive medical prescription opioid use as well as any misuse and the primary outcome was adolescent past 12-month medical prescription opioid use or any misuse.
The cohort included 15,200 total parent-adolescent pairs made up of 9400 mother-child and 5800 father-child pairs. The children were aged 12 to 17 years and a slight majority were male. When controlled for other factors, parental prescription opioid use was linked with adolescent prescription opioid medical use adjusted odds ratio [aOR], 1.28; 95% CI, 1.06-1.53) as well as opioid misuse (aOR, 1.53; 95% CI, 1.07-2.25), but parental misuse was not associated. Additionally, parental use of prescription stimulant was linked with adolescent medical prescription opioid use (aOR, 1.40; 95% CI, 1.02-1.91). Adolescent prescription opioid misuse linked with parent-adolescent conflict (aOR, 1.26; 95% CI, 1.05-1.52), adolescent depression (aOR, 1.75; 95% CI, 1.26-2.44), and parental marijuana use (aOR, 1.84; 95% CI, 1.13-2.99). Delinquency (aOR, 1.55; 95% CI, 1.38-1.74) and perceived schoolmates’ drug use (aOR, 2.87; 95% CI, 1.95-4.23) were linked with misuse, but weakly linked to medical use.
The researchers concluded that parental use of prescription opioids was linked to their teenager’s prescription opioid use, but parental misuse was not linked. This means that restricting opioid prescribing for parents is an important public health goal. When parents are given a prescription for opioids, they should be told about the risk of use of the prescription drug on their child. Furthermore, they should be told to mitigate risks. Asking parents about such use should become a part of pediatric practice.
Reference
1. Griesler P, Hu M, Wall M, Kandel D. Assessment of prescription opioid medical use and misuse among parents and their adolescent offspring in the US. JAMA Netw Open. 2021;4(1):e2031073. doi:10.1001/jamanetworkopen.2020.31073
Low vitamin D levels associated with slowed fracture healing
September 29th 2024“Getting outside and enjoying the fresh air can do wonders for your health while also upping Vitamin D absorption, said Jessica McQuerry, MD, lead study author of an abstract presented at the 2024 AAP National Conference & Exhibition.
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.